COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 698: Articles 6971-6980  | Next

Pre-existing immunity modulates responses to mRNA boosters
Dangi, T., Sanchez, S., Lew, M. H., Visvabharathy, L., Richner, J. M., Koralnik, I., Penaloza-MacMaster, P.
10.1101/2022.06.27.497248 — Posted: 2022-06-28
Structure-based inhibitor optimization for the Nsp3 Macrodomain of SARS-CoV-2
Gahbauer, S., Correy, G. J., Schuller, M., Ferla, M. P., Doruk, Y. U., Rachman, M., Wu, T., Diolaiti, M., Wang, S., Neitz, J., Fearon, D., Radchenko, D. S., Moroz, Y., Irwin, J. J., Renslo, A. R., Taylor, J. C., Gestwicki, J. E., von Delft, F., Ashworth, A., Ahel, I., Shoichet, B. K., Fraser, J. S.
10.1101/2022.06.27.497816 — Posted: 2022-06-28
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Davies, M.-A., Morden, E., Rosseau, P., Arendse, J., Bam, J.-L., Boloko, L., Cloete, K., Cohen, C., Chetty, N., Dane, P., Heekes, A., Hsiao, N.-Y., Hunter, M., Hussey, H., Jacobs, T., Jassat, W., Kariem, S., Kassanjee, R., Laenen, I., Le Roux, S., Lessells, R., Mahomed, H., Maughan, D., Meintjes, G., Mendelson, M., Mnguni, A., Moodley, M., Murie, K., Naude, J., Ntusi, N. A. B., Paleker, M., Parker, A., Pienaar, D., Preiser, W., Prozesky, H., Raubenheimer, P., Rossouw, L., Schreuder, N., Smith, B., Smith, M., Solomon, W., Symons, G., Taljaard, J., Wasserman, S., Wilkisnon, R., Wolmarans, M., Wolter, N., Boulle, A., Western Cape Department of Health and Wellness, , National Departments of Health, , National Institute for Communicable Diseases in South Africa
10.1101/2022.06.28.22276983 — Posted: 2022-06-28
The COVID-19 pandemic sparked off a large-scale outbreak of carbapenem-resistant Acinetobacter baumannii from the endemic strains of an Italian hospital
Petazzoni, G., Bellinzona, G., Merla, C., Corbella, M., Samuelsen, O., Corander, J., Sassera, D., Gaiarsa, S., Cambieri, P.
10.1101/2022.06.28.22276851 — Posted: 2022-06-28
BNT162b2 effectiveness against Delta & Omicron variants in teens by dosing interval and duration
Ionescu, I. G., Skowronski, D. M., Sauvageau, C., Chuang, E., Ouakki, M., Kim, S., De Serres, G.
10.1101/2022.06.27.22276790 — Posted: 2022-06-28
Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study
Byrne, M. H. V., Georgiades, F., Light, A., Lovegrove, C., Dominic, C., Rahman, J., Kathiravelupillai, S., Klatte, T., Saeb-Parsy, K., Kumar, R., Stewart, G. D., Turney, B., Wiseman, O., COVID Stones Collaborative
10.1101/2022.06.27.22276955 — Posted: 2022-06-28
Transition to Endemic: Acceptance of Additional COVID-19 Vaccine Doses Among Canadian Adults in A National Cross-Sectional Survey
Reifferscheid, L., Lee, J. S. W., MacDonald, N. E., Sadarangani, M., Assi, A., Lemaire-Paquette, S., MacDonald, S. E.
10.1101/2022.06.27.22276870 — Posted: 2022-06-28
Points-Based Models for Predicting Severe Disease related to Covid-19 with the SARS-CoV-2 Omicron Variant
Ben Shlomo, Y., Waxman, J. G., Shaham, G., Netzer, D., Reis, B., Balicer, R., Dagan, N.
10.1101/2022.06.27.22276907 — Posted: 2022-06-28
The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: A retrospective observational cohort study from recent regional outbreaks in China
Li, H., Zhu, X., Yu, R., Qian, X., Huang, Y., Chen, X., Lin, H., Zheng, H., Zhang, Y., Lin, J., Deng, Y., Zhong, W., Ji, Y., Li, Q., Fang, J., Yang, X., Lin, R., Chen, S., Su, Z., Xie, B., Li, H.
10.1101/2022.06.28.22276985 — Posted: 2022-06-28
Hand Dermatitis among Health Care Workers during the COVID-19 Pandemic: Prevalence, and Risk Factors
Motamed-Rezaei, O., Sharif-Zadeh, G., Rajabipour, H., Jahani, F., Lotfi, H.
10.1101/2022.06.27.22276976 — Posted: 2022-06-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).